The primary objective of dose escalation studies is to ensure safety and efficacy. By identifying the MTD and OBD, researchers can mitigate the risk of adverse effects and enhance the therapeutic benefits of the drug. These studies also help in understanding the dose-response relationship, which is crucial for dose optimization in subsequent phases of clinical trials.
